Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

She received one of the five highly contested 2015 L’Oréal-UNESCO UK & Ireland For Women In Science Fellowships.

L’Oréal joined forces with UNESCO 17 years ago to form a programme to encourage greater participation of women in science. The fellowship programmes, which run all over the world, promote and reward outstanding female postdoctoral researchers, offering flexible financial help.

Each worth £15,000, the fellowship can be spent on whatever they need to help drive their research forward. This year, the five winners will be using their prize money for a range of support such as buying equipment, carrying out field trips, attending conferences, getting help in their labs, as well as covering childcare costs. The fellows will also benefit from media training, personal impact coaching, speaking opportunities, networking events and access to senior mentors and role models.

The competition was extremely tough with a record 350 candidates applying for the five fellowships. The winners were selected by a jury of eminent scientists and announced at a ceremony at the Royal Society.

Dr Jagannath's work is all about 'Setting the body clock'. All organisms display 24-hour rhythms in physiology and behaviour, as can be seen in the sleep-wake cycle, but also including rhythms in blood pressure, body temperature and even cognitive ability. These rhythms are driven by a circadian clock (body clock) that is a molecular pacemaker occurring in most cells throughout the body.

We understand the molecular mechanisms that generate circadian clocks, but we have very little idea of how this clock is set to the correct time. Dr Jagannath proposes to use cellular models of the clock to identify the signalling pathways that relay environmental information to the clock. She will do this by testing a range of drugs and biological molecules for their ability to modify the clock and follow through with studies to identify the mechanism by which these molecules have their effect.

Sleep and circadian rhythm disruption is endemic to our 24/7 societies and we are now discovering that disruption of the clock can lead to obesity, diabetes and even mental health disorders such as bipolar disease. As a result, there is to be much gained from understanding how the molecular clock is regulated, and by extension, how we may be able to modulate its function when disrupted.

Similar stories

New genetic diagnosis technology for eye disease receives major funding award

Eye2Gene explores the use of AI to determine which genetic condition is causing a patient’s inherited retinal disease, by examining eye scans.

Royal Commission Industrial Fellowship for Andrei-Claudiu Roibu with F. Hoffmann-La Roche Ltd

Mapping brain network activity from structural connectivity using deep learning

Researchers awarded Wellcome Innovator Grant to investigate role of brainstem nucleus in human consciousness

Researchers at Oxford University have received a prestigious Wellcome Innovator Grant for investigating the role of the pedunculopontine nucleus (PPN) – a brainstem nucleus – in human consciousness.

How our dreams changed during the COVID-19 pandemic

This study explored associations between COVID-19 and dream recall frequency, and related social, health, and mental health factors.

New insights into the effect of exposure to dim light in the evening on the biology of the sleep-wake cycle

A new study has revealed more about how exposure to dim light in the evening affects circadian health. The findings emphasise the need to optimise our artificial light exposure if we are to avoid shifting our biological clocks.

International study finds insomnia, anxiety and depression very prevalent during first phase of COVID-19 pandemic

Researchers are recommending public health interventions to reduce the long-term adverse outcomes associated with chronic insomnia and mental health problems.